fr.villalobos
Submits third-party assay reports on material purchased directly. Based in Osaka.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.05%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042406 | Retatrutide | Homopeptide | HOMO-2601-J3763 | Janoshik | 2026-Q1 | 99.04 | 5.06 | 90.8 | Buyer-sourced | 0 | PASS |
| AX-2025-020719 | BPC-157 | SGN | SGN-2507-F9360 | PeptideMeter | 2025-Q3 | 98.50 | 4.74 | 95.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020974 | PT-141 (Bremelanotide) | WXT | WXT-2507-R4042 | VendorInvestigate | 2025-Q3 | 99.38 | 4.71 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018888 | CJC-1295 (no DAC) | TFS | TFS-{CAT}-9097 | Medutest | 2025-Q2 | 99.12 | 4.20 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018472 | Tirzepatide | WWB | WWB-2502-U2990 | Janoshik | 2025-Q1 | 99.05 | 3.24 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019215 | BPC-157 | SinoPep | SNP-2408-Y4383 | Janoshik | 2025-Q1 | 98.99 | 2.92 | 89.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018850 | Dihexa | FGP | FGP-2408-S8496 | Kestrel | 2025-Q1 | 99.69 | 7.31 | 95.1 | Buyer-sourced | 0 | PASS |